Calidi Biotherapeutics Stock (AMEX: CLDI) stock price, news, charts, stock research, profile.
You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.
Other companies in Calidi Biotherapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS) and Nanoviricides (AMEX:NNVC).
Calidi Biotherapeutics has a consensus price target of $1.67.
The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $1.35 last updated December 20, 2024 at 6:30 PM EST.
There are no upcoming dividends for Calidi Biotherapeutics.
Calidi Biotherapeutics’s Q4 earnings are confirmed for Friday, March 14, 2025.
There is no upcoming split for Calidi Biotherapeutics.
Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.